Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-001371
Filing Date
2024-09-23
Accepted
2024-09-23 17:27:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 8861
  Complete submission text file 0001972362-24-001371.txt   10334
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33093 | Film No.: 241317102
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address
Korenberg Matthew E (Reporting) CIK: 0001649903 (see all company filings)

Type: 144